Home » Topics » Conferences

Conferences
RSS

Merck develops potent, short-acting, orally active GH secretagogues

March 31, 1999

Kyorin describes production, synthesis and structure of novel antibacterial substance

March 31, 1999

Potent new SERM related to raloxifene presented at ACS meeting by Lilly

March 31, 1999

Studies on BTK inhibitors expected to result in discovery of new anticancer drugs

March 31, 1999

Liposomal antiseptic enters clinical testing at Mundipharma

March 31, 1999

ACS highlights: Dainippon selects potent antitumor compound for development

March 30, 1999

More news from the ACS: DuPont synthesizes anti-HIV compounds derived from efavirenz

March 30, 1999

New antileukemia agents synthesized at Hughes Institute

March 30, 1999

In vitro data supporting antifungal efficacy of Nyotran presented at ECCMID

March 30, 1999

Studies show that ketolide compound ABT-773 is a promising new antimicrobial agent

March 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...